According to GoodRx's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.63894. At the end of 2022 the company had a P/S ratio of 2.34.
Year | P/S ratio | Change |
---|---|---|
2022 | 2.34 | -86.64% |
2021 | 17.5 | -39% |
2020 | 28.7 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
![]() Perion Network PERI | 2.54 | -3.87% | ๐ฎ๐ฑ Israel |